Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2010
11/25/2010WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010134846A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
11/25/2010WO2010133794A1 Anticancer compound and pharmaceutical composition containing the same
11/25/2010WO2010133318A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
11/25/2010WO2010132951A1 Oligothiophenes and uses thereof in photovoltaic devices
11/25/2010WO2010114928A3 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
11/25/2010WO2010112826A3 Quinoline or naphthyridine herbicides
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2010056585A3 Heteroaryl diamide compounds useful as mmp-13 inhibitors
11/25/2010WO2010003533A3 Pyridopyrimidine compounds as anti-tubercular agents
11/25/2010WO2009142842A9 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2010US20100298566 Process for the preparation of paliperidone and its intermediates
11/25/2010US20100298562 Pyridazine and Pyrrole Compounds, Processes For Obtaining Them and Uses
11/25/2010US20100298374 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010US20100298342 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
11/25/2010US20100298339 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use
11/25/2010US20100298320 Pyrido[2,3-b]pyrazin-8-substituted Compounds and Their Use
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
11/25/2010US20100298306 (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease
11/25/2010US20100298303 Cgrp receptor antagonists
11/25/2010US20100298288 Cetp inhibitors derived from benzoxazole arylamides
11/25/2010US20100298287 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
11/25/2010US20100297128 Gamma secretase modulators
11/25/2010US20100297009 Self-assembled polyhedral multimeric chemical structures
11/25/2010US20100294998 Aromatic imide-based dispersant for carbon nanotubes and carbon nanotube composition comprising the same
11/25/2010CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010CA2762233A1 Anticancer compound and pharmaceutical composition containing the same
11/25/2010CA2759939A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252614A1 Novel 3,8-diaza-bicyclo[3.2.1]octane- and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2010EP2252613A1 Compounds and compositions as modulators of gpr119 activity
11/24/2010EP2252612A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
11/24/2010EP2252611A1 (dihydro)pyrrolo[2,1-a]isoquinolines
11/24/2010EP1934216B1 Naphthyridin derivatives
11/24/2010EP1917263B1 Process for the preparation of imidazopyridines
11/24/2010EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/24/2010EP1638970B1 Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors
11/24/2010EP1539739B1 Piperidinyl compounds that selectively bind integrins
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
11/24/2010CN1578660B Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/24/2010CN101896479A Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
11/24/2010CN101891740A Method for extracting laburnine from upper part of thermopsis lanceolate
11/24/2010CN101891739A Pyridino-uracil peptide nucleic acid monomer and intermediate thereof as well as preparation method and application of same
11/24/2010CN101891627A Ruthenium-containing coordination compound and preparation method thereof
11/24/2010CN101890018A Tyrosine protein kinase inhibitor and preparation method thereof
11/24/2010CN101139347B Banisterine derivative compound and uses thereof
11/23/2010US7838681 Synthesis of substituted heterocyclic compounds
11/23/2010US7838674 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2
11/23/2010US7838533 Azaindole inhibitors of MTP and ApoB
11/23/2010US7838527 Methods of treating cancer and related methods
11/23/2010CA2599860C 1, 2, 4-triazole derivatives and their use as oxytocin antagonists
11/23/2010CA2496295C Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
11/23/2010CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
11/23/2010CA2440014C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010130665A1 Azacyclic spiroderivatives as hsl inhibitors
11/18/2010WO2010130424A1 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/18/2010WO2010130423A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010WO2010130422A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010WO2010130147A1 Pyronaridine lactate, pharmaceutical composition and use thereof
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010108074A3 Inhibitors of pi3 kinase
11/18/2010WO2010107791A3 Pyrazinoisoquinoline compounds
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010US20100292479 Novel compound having affinity for amyloid
11/18/2010US20100292477 Solid forms and process for preparing
11/18/2010US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/18/2010US20100292262 4 (pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-amine derivatives
11/18/2010US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators
11/18/2010US20100292250 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010US20100292243 7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
11/18/2010US20100292242 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
11/18/2010US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives
11/18/2010US20100292238 Phenoxymethyl Heterocyclic Compounds
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292232 Non-nucleoside reverse transcriptase inhibitors
11/18/2010US20100292231 Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
11/18/2010US20100292225 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010US20100292212 New azacyclic derivatives
11/18/2010US20100292196 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2760837A1 7-([1,2,4]triazolo[1,5,-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
11/18/2010CA2760778A1 Heteroaryl compounds as pikk inhibitors
11/18/2010CA2760741A1 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/18/2010CA2760340A1 Azacyclic spiroderivatives as hsl inhibitors
11/18/2010CA2760259A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010CA2760084A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/17/2010EP2251341A1 Heterocyclic Janus kinase 3 inhibitors
11/17/2010EP2251340A1 Substituted tetrahydro-1h-pyrazolo[3,4-c] pyridines, compositions containing same and use thereof
11/17/2010EP2251339A2 Compounds